Letter to the Editor
Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients
Enfermedad pulmonar intersticial post-COVID 19: Un nuevo reto de tratamiento en pacientes con artritis reumatoide
Read
1412
Timeswas read the article
453
Total PDF
959
Total HTML
Share statistics
array:24 [ "pii" => "S2173574322001630" "issn" => "21735743" "doi" => "10.1016/j.reumae.2022.06.005" "estado" => "S300" "fechaPublicacion" => "2022-12-01" "aid" => "1631" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2022;18:625-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S1699258X2200153X" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2022.06.002" "estado" => "S300" "fechaPublicacion" => "2022-12-01" "aid" => "1631" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2022;18:625-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "625" "paginaFinal" => "626" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad pulmonar intersticial post-COVID 19: Un nuevo reto de tratamiento en pacientes con artritis reumatoide" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 421 "Ancho" => 1405 "Tamanyo" => 96023 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evolution of the CT scan of the patient.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jose Luis Morell-Hita, Juan A. Rigual-Bobillo, Cristina C. Macía-Villa" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "Morell-Hita" ] 1 => array:2 [ "nombre" => "Juan A." "apellidos" => "Rigual-Bobillo" ] 2 => array:2 [ "nombre" => "Cristina C." "apellidos" => "Macía-Villa" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574322001630" "doi" => "10.1016/j.reumae.2022.06.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574322001630?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X2200153X?idApp=UINPBA00004M" "url" => "/1699258X/0000001800000010/v1_202211240631/S1699258X2200153X/v1_202211240631/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574322001642" "issn" => "21735743" "doi" => "10.1016/j.reumae.2022.05.001" "estado" => "S300" "fechaPublicacion" => "2022-12-01" "aid" => "1628" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2022;18:626-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Long COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: Similarities and differences of two peas in a pod" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "626" "paginaFinal" => "628" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "COVID-19 persistente y encefalomielitis miálgica/síndrome de fatiga crónica: similitudes y diferencias" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rami Qanneta" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Rami" "apellidos" => "Qanneta" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1699258X22001346" "doi" => "10.1016/j.reuma.2022.05.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X22001346?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574322001642?idApp=UINPBA00004M" "url" => "/21735743/0000001800000010/v1_202211240657/S2173574322001642/v1_202211240657/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173574321001933" "issn" => "21735743" "doi" => "10.1016/j.reumae.2021.04.007" "estado" => "S300" "fechaPublicacion" => "2022-12-01" "aid" => "1549" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2022;18:624" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Response to “Subclinical interstitial lung disease in patients with systemic sclerosis. A pilot study on the role of ultrasound”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "624" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta a «Intersticiopatía pulmonar subclínica en pacientes con esclerosis sistémica. Estudio piloto sobre el papel del ultrasonido»" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Esther F. Vicente-Rabaneda, David Bong, Ingrid Möller, Santos Castañeda" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Esther F." "apellidos" => "Vicente-Rabaneda" ] 1 => array:2 [ "nombre" => "David" "apellidos" => "Bong" ] 2 => array:2 [ "nombre" => "Ingrid" "apellidos" => "Möller" ] 3 => array:2 [ "nombre" => "Santos" "apellidos" => "Castañeda" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X21001546" "doi" => "10.1016/j.reuma.2021.04.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X21001546?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321001933?idApp=UINPBA00004M" "url" => "/21735743/0000001800000010/v1_202211240657/S2173574321001933/v1_202211240657/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "625" "paginaFinal" => "626" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Jose Luis Morell-Hita, Juan A. Rigual-Bobillo, Cristina C. Macía-Villa" "autores" => array:3 [ 0 => array:3 [ "nombre" => "Jose Luis" "apellidos" => "Morell-Hita" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Juan A." "apellidos" => "Rigual-Bobillo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:4 [ "nombre" => "Cristina C." "apellidos" => "Macía-Villa" "email" => array:1 [ 0 => "ccmacia@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario Ramón y Cajal, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad pulmonar intersticial post-COVID 19: Un nuevo reto de tratamiento en pacientes con artritis reumatoide" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 421 "Ancho" => 1405 "Tamanyo" => 96023 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evolution of the CT scan of the patient.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The coronavirus disease 2019 (COVID-19) is the result of infection with the SARS-CoV-2 virus that is making us live one of the worst pandemics of the 21st century. It has affected the management of rheumatoid arthritis (RA), since these patients are treated with immunosuppressants such as disease-modifying drugs and biologics (bDMARDs). At the beginning of the pandemic, when a patient with RA required hospital admission for COVID-19, immunosuppression was suspended until improvement.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a> Over time, we have learned about SARS-CoV-2 infection, showing that use of bDMARDs is not associated with worse outcomes<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">2</span></a> except for rituximab and JAK inhibitors.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">However, the management is challenging. When a patient with RA without prior interstitial lung disease (ILD) is hospitalized with severe SARS-CoV-2 pneumonia passes the acute phase, and suffers a flare of RA, there is an understandable concern to reintroduce immunosuppression. In this phase, the patient is normally still on low-dose steroid treatment, but the bDMARDs that can be used for SARS-CoV-2 infection have been stopped (such as tocilizumab or bariticinib, also useful for RA). Therefore, the rheumatologist must decide to reintroduce the RA baseline treatment or to change it due to the new ILD secondary to the virus. We would like to share our experience.</p><p id="par0015" class="elsevierStylePara elsevierViewall">We present the case of a 72-year-old woman with RA since 1997 treated with 25<span class="elsevierStyleHsp" style=""></span>mg of methotrexate (MTX) weekly and 125<span class="elsevierStyleHsp" style=""></span>mg of abatacept weekly, in remission. In 2018 she complained of a dry cough and was studied with CT scan (normal, <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A), and finally diagnosed with gastric reflux.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">In March 2020, she was admitted to the intensive care unit for severe global bilateral SARS-CoV-2 pneumonia. MTX and abatacept were suspended, she was intubated and treated with corticosteroids, antivirals, and later tocilizumab. Her evolution was favorable, but on the 40th day of hospitalization, despite maintaining 0.5<span class="elsevierStyleHsp" style=""></span>mg/kg of prednisone, she presented a severe polyarticular RA flare. At that time, MTX and abatacept were reintroduced. She has been in remission to date.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In September 2020, one month after hospital discharge, she was still reporting stable dyspnea on moderate efforts, the CT scan was as shown in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B (ground glass areas and thickening of interlobular septa in both lower lobes, patchy ground consolidation in all lobes, and honeycomb changes in the left upper lobe), and the functional tests were as follows: FEV1 2140<span class="elsevierStyleHsp" style=""></span>ml (104% of predicted value), FVC 2620<span class="elsevierStyleHsp" style=""></span>ml (99%), DLco (corrected for hemoglobin) 3030<span class="elsevierStyleHsp" style=""></span>mmol/kPa/min (49%). She was treated by pneumologists with a descending dose of 0.5<span class="elsevierStyleHsp" style=""></span>mg/kg of prednisone for a month. Six months later functional tests improved – FEV1 2240<span class="elsevierStyleHsp" style=""></span>ml (111%), FVC 2740<span class="elsevierStyleHsp" style=""></span>ml (105%), DLco 3950<span class="elsevierStyleHsp" style=""></span>mmol/kPa/min (64%) – as well as the CT scan (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>C). To date, she has not reported dyspnea and her baseline saturation is 99%. She has maintained MTX and abatacept without any adverse event or RA flare. NSAIDs or other corticosteroids have not been needed.</p><p id="par0030" class="elsevierStylePara elsevierViewall">There is another report of a RA patient maintaining 10<span class="elsevierStyleHsp" style=""></span>mg of MTX during the hospitalization period, and her condition remained stable.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">4</span></a> MTX does not have an increased risk of infections <a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">5</span></a>and is not associated with an increased risk of RA-ILD in RA.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">6</span></a> We suggest, sustained on current published data,<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">7–9</span></a> that reintroducing baseline treatment when RA patients surpass the critic phase of COVID-19 disease does not worsen the evolution of ILD secondary to SARS-CoV-2, as it appears to be independent. However, given that the bDMARD in our case is abatacept, which has a good ILD profile in patients with RA, it would be of great interest to collect more data with all DMARDs and bDMARDs in these patients.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 421 "Ancho" => 1405 "Tamanyo" => 96023 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evolution of the CT scan of the patient.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0050" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 1" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.R. Mikuls" 1 => "S.R. Johnson" 2 => "L. Fraenkel" 3 => "R.J. Arasaratnam" 4 => "L.R. Baden" 5 => "B.L. Bermas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.41301" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheumatol" "fecha" => "2020" "volumen" => "72" "paginaInicial" => "1241" "paginaFinal" => "1251" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32349183" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0055" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Gianfrancesco" 1 => "K.L. Hyrich" 2 => "S. Al-Adely" 3 => "L. Carmona" 4 => "M.I. Danila" 5 => "L. Gossec" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/annrheumdis-2020-217871" "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2020" "volumen" => "79" "paginaInicial" => "859" "paginaFinal" => "866" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32471903" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0060" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.A. Sparks" 1 => "Z.S. Wallace" 2 => "A.M. Seet" 3 => "M.A. Gianfrancesco" 4 => "Z. Izadi" 5 => "K.L. Hyrich" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/annrheumdis-2021-220418" "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2021" "volumen" => "80" "paginaInicial" => "1137" "paginaFinal" => "1146" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34049860" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0065" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "COVID-19 with rheumatic diseases: a report of 5 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Cheng" 1 => "C. Li" 2 => "T. Zhao" 3 => "J. Yue" 4 => "F. Yang" 5 => "Y. Yan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10067-020-05160-x" "Revista" => array:5 [ "tituloSerie" => "Clin Rheumatol" "fecha" => "2020" "volumen" => "39" "paginaInicial" => "2025" "paginaFinal" => "2029" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0070" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The risk of hospitalized infection in patients with rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.L. Smitten" 1 => "H.K. Choi" 2 => "M.C. Hochberg" 3 => "S. Suissa" 4 => "T.A. Simon" 5 => "M.A. Testa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "2008" "volumen" => "35" "paginaInicial" => "387" "paginaFinal" => "393" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18260176" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0075" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Methotrexate and rheumatoid arthritis associated interstitial lung disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.-A. Juge" 1 => "J.S. Lee" 2 => "J. Lau" 3 => "L. Kawano-Dourado" 4 => "J. Rojas Serrano" 5 => "M. Sebastiani" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/13993003.00337-2020" "Revista" => array:5 [ "tituloSerie" => "Eur Respir J" "fecha" => "2021" "volumen" => "57" "paginaInicial" => "2000337" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32646919" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0080" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Post-acute COVID-19 syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Nalbandian" 1 => "K. Sehgal" 2 => "A. Gupta" 3 => "M.V. Madhavan" 4 => "C. McGroder" 5 => "J.S. Stevens" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41591-021-01283-z" "Revista" => array:6 [ "tituloSerie" => "Nat Med" "fecha" => "2021" "volumen" => "27" "paginaInicial" => "601" "paginaFinal" => "615" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33753937" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0085" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Huang" 1 => "L. Huang" 2 => "Y. Wang" 3 => "X. Li" 4 => "L. Ren" 5 => "X. Gu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(20)32656-8" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2021" "volumen" => "397" "paginaInicial" => "220" "paginaFinal" => "232" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33428867" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0090" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Northwestern Comprehensive COVID Center Consortium. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.J. Mylvaganam" 1 => "J.I. Bailey" 2 => "J.I. Sznajder" 3 => "M.A. Sala" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/16000617.0194-2021" "Revista" => array:5 [ "tituloSerie" => "Eur Respir Rev" "fecha" => "2021" "volumen" => "30" "paginaInicial" => "210194" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34911696" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001800000010/v1_202211240657/S2173574322001630/v1_202211240657/en/main.assets" "Apartado" => array:4 [ "identificador" => "8400" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001800000010/v1_202211240657/S2173574322001630/v1_202211240657/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574322001630?idApp=UINPBA00004M" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 7 | 1 | 8 |
| 2024 October | 49 | 22 | 71 |
| 2024 September | 54 | 16 | 70 |
| 2024 August | 82 | 29 | 111 |
| 2024 July | 53 | 29 | 82 |
| 2024 June | 71 | 27 | 98 |
| 2024 May | 87 | 28 | 115 |
| 2024 April | 76 | 22 | 98 |
| 2024 March | 62 | 28 | 90 |
| 2024 February | 60 | 22 | 82 |
| 2024 January | 66 | 17 | 83 |
| 2023 December | 48 | 32 | 80 |
| 2023 November | 32 | 33 | 65 |
| 2023 October | 32 | 30 | 62 |
| 2023 September | 89 | 37 | 126 |
| 2023 August | 30 | 16 | 46 |
| 2023 July | 26 | 24 | 50 |
| 2023 June | 29 | 36 | 65 |
| 2023 March | 6 | 4 | 10 |
Show all
